245 related articles for article (PubMed ID: 30067880)
1. PD-L1 and IDO expression in cervical and vulvar invasive and intraepithelial squamous neoplasias: implications for combination immunotherapy.
Chinn Z; Stoler MH; Mills AM
Histopathology; 2019 Jan; 74(2):256-268. PubMed ID: 30067880
[TBL] [Abstract][Full Text] [Related]
2. Looking past PD-L1: expression of immune checkpoint TIM-3 and its ligand galectin-9 in cervical and vulvar squamous neoplasia.
Curley J; Conaway MR; Chinn Z; Duska L; Stoler M; Mills AM
Mod Pathol; 2020 Jun; 33(6):1182-1192. PubMed ID: 32139873
[TBL] [Abstract][Full Text] [Related]
3. Loss of MHC Class I Expression in HPV-associated Cervical and Vulvar Neoplasia: A Potential Mechanism of Resistance to Checkpoint Inhibition.
Dibbern ME; Bullock TN; Jenkins TM; Duska LR; Stoler MH; Mills AM
Am J Surg Pathol; 2020 Sep; 44(9):1184-1191. PubMed ID: 32496434
[TBL] [Abstract][Full Text] [Related]
4. Indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase expression in HPV infection, SILs, and cervical cancer.
Venancio PA; Consolaro MEL; Derchain SF; Boccardo E; Villa LL; Maria-Engler SS; Campa A; Discacciati MG
Cancer Cytopathol; 2019 Sep; 127(9):586-597. PubMed ID: 31412167
[TBL] [Abstract][Full Text] [Related]
5. Expressions of programmed death (PD)-1 and PD-1 ligand (PD-L1) in cervical intraepithelial neoplasia and cervical squamous cell carcinomas are of prognostic value and associated with human papillomavirus status.
Yang W; Lu YP; Yang YZ; Kang JR; Jin YD; Wang HW
J Obstet Gynaecol Res; 2017 Oct; 43(10):1602-1612. PubMed ID: 28833798
[TBL] [Abstract][Full Text] [Related]
6. Landscape of Immune Checkpoint Inhibition in Carcinosarcoma (MMMT): Analysis of IDO-1, PD-L1 and PD-1.
Hacking S; Chavarria H; Jin C; Perry A; Nasim M
Pathol Res Pract; 2020 Apr; 216(4):152847. PubMed ID: 32085927
[TBL] [Abstract][Full Text] [Related]
7. Fascin and cyclin D1 immunoreactivity in non-neoplastic vulvar squamous epithelium, vulvar intraepithelial neoplasia and invasive squamous carcinoma: correlation with Ki67 and p16 protein expression.
Stewart CJ; Crook ML
J Clin Pathol; 2014 Apr; 67(4):319-25. PubMed ID: 24218024
[TBL] [Abstract][Full Text] [Related]
8. Programmed death-ligand 1 (PD-L1) is expressed in a significant number of the uterine cervical carcinomas.
Reddy OL; Shintaku PI; Moatamed NA
Diagn Pathol; 2017 Jun; 12(1):45. PubMed ID: 28623908
[TBL] [Abstract][Full Text] [Related]
9. Targetable Immune Regulatory Molecule Expression in High-Grade Serous Ovarian Carcinomas in African American Women: A Study of PD-L1 and IDO in 112 Cases From the African American Cancer Epidemiology Study (AACES).
Mills AM; Peres LC; Meiss A; Ring KL; Modesitt SC; Abbott SE; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy ML; Cote ML; Funkhouser E; Moorman PG; Peters ES; Schwartz AG; Terry PD; Wallace K; Schildkraut JM
Int J Gynecol Pathol; 2019 Mar; 38(2):157-170. PubMed ID: 29485423
[TBL] [Abstract][Full Text] [Related]
10. PD-L1/PD1 Expression, Composition of Tumor-Associated Immune Infiltrate, and HPV Status in Conjunctival Squamous Cell Carcinoma.
Nagarajan P; El-Hadad C; Gruschkus SK; Ning J; Hudgens CW; Sagiv O; Gross N; Tetzlaff MT; Esmaeli B
Invest Ophthalmol Vis Sci; 2019 May; 60(6):2388-2398. PubMed ID: 31141610
[TBL] [Abstract][Full Text] [Related]
11. Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and Vulva.
Howitt BE; Sun HH; Roemer MG; Kelley A; Chapuy B; Aviki E; Pak C; Connelly C; Gjini E; Shi Y; Lee L; Viswanathan A; Horowitz N; Neuberg D; Crum CP; Lindeman NL; Kuo F; Ligon AH; Freeman GJ; Hodi FS; Shipp MA; Rodig SJ
JAMA Oncol; 2016 Apr; 2(4):518-22. PubMed ID: 26913631
[TBL] [Abstract][Full Text] [Related]
12. The immune checkpoints CTLA-4 and PD-L1 in carcinomas of the uterine cervix.
Karpathiou G; Chauleur C; Mobarki M; Peoc'h M
Pathol Res Pract; 2020 Jan; 216(1):152782. PubMed ID: 31862202
[TBL] [Abstract][Full Text] [Related]
13. Indoleamine 2,3-dioxygenase in endometrial cancer: a targetable mechanism of immune resistance in mismatch repair-deficient and intact endometrial carcinomas.
Mills A; Zadeh S; Sloan E; Chinn Z; Modesitt SC; Ring KL
Mod Pathol; 2018 Aug; 31(8):1282-1290. PubMed ID: 29559741
[TBL] [Abstract][Full Text] [Related]
14. HLA-G, HLA-E, and IDO overexpression predicts a worse survival of Tunisian patients with vulvar squamous cell carcinoma.
Boujelbene N; Ben Yahia H; Babay W; Gadria S; Zemni I; Azaiez H; Dhouioui S; Zidi N; Mchiri R; Mrad K; Ouzari HI; Charfi L; Zidi I
HLA; 2019 Jul; 94(1):11-24. PubMed ID: 30907063
[TBL] [Abstract][Full Text] [Related]
15. IDO expression in breast cancer: an assessment of 281 primary and metastatic cases with comparison to PD-L1.
Dill EA; Dillon PM; Bullock TN; Mills AM
Mod Pathol; 2018 Oct; 31(10):1513-1522. PubMed ID: 29802358
[TBL] [Abstract][Full Text] [Related]
16. PD-L1 expression and survival in p16-negative and -positive squamous cell carcinomas of the vulva.
Czogalla B; Pham D; Trillsch F; Rottmann M; Gallwas J; Burges A; Mahner S; Kirchner T; Jeschke U; Mayr D; Schmoeckel E
J Cancer Res Clin Oncol; 2020 Mar; 146(3):569-577. PubMed ID: 32025868
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of Program Death Ligand-1 and Indoleamine-2,3-Dioxygenase Expression in Colorectal Carcinoma.
Hacking S; Vitkovski T; Jain S; Jin C; Chavarria H; Wu D; Nasim M
Appl Immunohistochem Mol Morphol; 2021 Mar; 29(3):201-208. PubMed ID: 32842025
[TBL] [Abstract][Full Text] [Related]
18. Histopathologic study of thin vulvar squamous cell carcinomas and associated cutaneous lesions: a correlative study of 48 tumors in 44 patients with analysis of adjacent vulvar intraepithelial neoplasia types and lichen sclerosus.
Chiesa-Vottero A; Dvoretsky PM; Hart WR
Am J Surg Pathol; 2006 Mar; 30(3):310-8. PubMed ID: 16538050
[TBL] [Abstract][Full Text] [Related]
19. Indoleamine-2,3-Dioxygenase in Non-Small Cell Lung Cancer: A Targetable Mechanism of Immune Resistance Frequently Coexpressed With PD-L1.
Volaric A; Gentzler R; Hall R; Mehaffey JH; Stelow EB; Bullock TN; Martin LW; Mills AM
Am J Surg Pathol; 2018 Sep; 42(9):1216-1223. PubMed ID: 29901571
[TBL] [Abstract][Full Text] [Related]
20. PD-L1 receptor expression in vulvar carcinomas is HPV-independent.
Choschzick M; Gut A; Fink D
Virchows Arch; 2018 Oct; 473(4):513-516. PubMed ID: 29736798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
